Menu
Not yet recruiting NCT06683209

Optimizing Patient's Comfort During Scleral Indentation

No phase Interventional Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Schocket scleral depressor, Josephberg-Besser, Cotton tip applicator.
Who it may be relevant to
Registry conditions: Pain. Basic parameters: 18 years — 100 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison of Scleral Indentation Instruments and Impact on Patient Comfort

Overview

The scleral depression exam is an important routine technique for evaluating the retinal periphery for various reasons. During this examination, an instrument is used to bring the anterior part of the retina into the physician's field of view. The downside of this technique is the discomfort it may cause the patient. Different instruments can be used to depress the sclera. The objective of this research is to compare three commonly used scleral depressors based on their performance for the ophthalmologist and the discomfort they subjectively induce in patients. Patients will be randomly allocated to one of three examination groups: Group A: One eye examined with the Schocket scleral depressor, the other eye with the Josephberg-Besser scleral depressor. Group B: One eye examined with the Schocket scleral depressor, the other eye with the cotton-tip applicator. Group C: One eye examined with the cotton-tip applicator, the other eye with the Josephberg-Besser scleral depressor.

Detailed description

Background The scleral depression exam is an important technique for evaluating the retinal periphery during indirect ophthalmoscopy. Despite the advent of ultra-widefield fundus imaging, scleral depression provides greater sensitivity in detecting peripheral lesions, such as retinal tears. It was found that 11% of retinal tears were missed when employing non-contact slit-lamp examination, compared to indirect ophthalmoscopy with scleral depression, and a scleral depression exam is widely considered the gold standard for ruling out retinal tears. While there is no international consensus, the preferred practice guideline (American Academy of Ophthalmology) for assessing peripheral vitreoretinal pathology is by indirect ophthalmoscopy combined with scleral depression.

There are a variety of ophthalmic instruments that an eye care professional may use to perform scleral depression. While the exam is uncomfortable, there is a lack of studies comparing patient comfort with different instruments. In this prospective study, we will compare subjective patient pain scores using the Schocket scleral depressor, the Josephberg-Besser scleral depressor, and the cotton-tipped applicator.

Purpose To assess patient pain scores for three common scleral indentation devices and determine which is most comfortable for patients.

Objective / Hypothesis Based on clinical experience, the hypothesis is that the Josephberg-Besser scleral depressor causes less discomfort due to its design.

Study Design Prospective comparative analysis.

Methods Patients will be recruited at two tertiary referral centers (Alberta Retinal Consultants, Edmonton, Alberta, and Sunnybrook Hospital, Department of Ophthalmology \& Vision Sciences, Toronto, Ontario) upon consent to participate. Subject identification will be based on the referral indication (symptomatic posterior vitreous detachment with or without vitreoretinal pathology) and the absence of exclusion criteria (i.e., patients who require a scleral indentation examination based on the presenting symptoms). Patients will then be randomly allocated to one of three groups. Additionally, within each group, the symptomatic eye will be randomized.

Patients will be dilated with 1% tropicamide and 2.5% phenylephrine for 30 minutes. Instillation of local anesthetic drops will be used to eliminate any confounding exposure-related keratalgia or ocular surface irritation. Indirect ophthalmoscopic evaluation of the retinal periphery will be undertaken using the provider's lens of choice (20 or 28-diopter lens). The lens and illumination settings will be kept the same for each eye. A similar amount of time and effort will be spent on both eyes.

Following the examination, both patients and physicians will be asked to provide responses to the survey questions provided (surveys enclosed).

Statistical analysis will be performed using R statistical software. Randomization to treatment will be created using Python programming software.

Exclusions:

Monocular status. Media opacity that precludes view of the peripheral retina. Inadequate examination (cooperation with examination, inability to achieve all directions of gaze).

Underlying oculodynia (recent surgery, intraocular inflammation, abnormal intraocular pressure, ocular dysesthesia syndromes (ocular, adnexal, or orbital)).

History of pain-sensitizing conditions or current analgesic use. Previous scleral indentation examination poorly tolerated.

Interventions

  • Diagnostic test Schocket scleral depressor
    Use of this instrument to examine one eye
  • Diagnostic test Josephberg-Besser
    Use of this instrument to examine one eye
  • Diagnostic test Cotton tip applicator
    Use of this instrument to examine one eye

Primary outcome measures

  • Pain scale [Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.]
Secondary outcome measures (6)
  • Ergonomics Ease of use [Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.]
  • Performance accessing the visualized area [Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.]
  • Quantity of indentation [Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.]
  • Performance achieving sufficient indentation [Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.]
  • Duration of examination [Time frame: Time mesure will be during the examination of each eye]
  • Degree of retinal pathology [Time frame: The physician will note his findings right after his examination, while completing his examination survey]

Eligibility criteria

Inclusion criteria

  • Symptomatic posterior vitreous detachment with or without vitreoretinal pathology

Exclusion criteria

  • Monocular status.
  • Media opacity which precludes view of the peripheral retina.
  • Inadequate examination (cooperation with examination, inability to achieve all directions of gaze).
  • Underlying oculodynia (recent surgery, intraocular inflammation, abnormal intraocular pressure, ocular dysesthesia syndromes (ocular, adnexal or orbital).
  • History of pain-sensitizing conditions or current analgesic use.
  • Previous scleral indented examination poorly tolerated.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Supportive care

Study locations

Canada · 2 centers
  • Alberta Retina Consultant — Edmonton
  • Sunnybrook Hospital — Toronto

Identifiers

NCT: NCT06683209 · Pro00146504

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗